The use of MelMax in the healing of chronic wounds

Area of Science:

• Wound Healing and Tissue Regeneration
• Biomaterials and Medical Devices
• Microbiology and Infectious Diseases

Background:

• Chronic wounds significantly impact patient quality of life and incur substantial healthcare costs.
• Delayed healing in chronic wounds is often attributed to an imbalance between matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs).
• High bacterial load in chronic wound beds is a major contributor to impaired healing.

Purpose of the Study:

• To explore the role of MMPs in the complex process of wound healing.
• To investigate the antimicrobial properties of honey as a therapeutic agent for wound infections.
• To introduce and evaluate a novel dressing (MelMax) that combines protease regulation with honey's antimicrobial action for chronic wound management.

Main Methods:

• Review of the literature on matrix metalloproteinases (MMPs) and their role in wound healing.
• Examination of the antimicrobial efficacy of honey in the context of wound dressings.
• Case studies demonstrating the clinical application and integration of the MelMax dressing in practice.

Main Results:

• An imbalance in MMPs and TIMPs disrupts the extracellular matrix, hindering chronic wound repair.
• Honey possesses significant antimicrobial properties beneficial for combating wound infections.
• The MelMax dressing effectively utilizes protease modulation and honey's antimicrobial action, as shown in short-term case studies.

Conclusions:

• Addressing MMP/TIMP imbalance and bacterial load is crucial for effective chronic wound management.
• Honey-based dressings offer a dual approach to healing by controlling infection and supporting protease balance.
• The MelMax dressing presents a promising new option for clinicians treating chronic wounds, supported by initial positive case study outcomes.